President Hollande was excited to hear about Exogen’s long-term goal to develop blood-based kits that can be used at home to pre-screen for potential disease such as cancer and aging. Hollande congratulated Tang and Costes for their noble cause and mentioned his own recent pledge to invest 1.5 billion euros in easing access to cancer treatment in France over the next five years.
Exogen is one of ten startups invited to present their technology to President Hollande of France during his visit to Silicon Valley on February 12, 2014. Exogen’s aims are in line with many of the strategic goals of Hollande’s Innovation 2030 Commission, such as big data, personalized medicine, and innovation in the service of longevity and aging. President Hollande will be given the opportunity to see Exogen’s technology first-hand.